$2.79 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 103 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 53.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLRN | Sell | ACCELERON PHARMA INC | $63,963,000 | +17.0% | 1,117,651 | -0.8% | 2.29% | +19.3% |
| MYOK | Sell | MYOKARDIA INC | $59,788,000 | +3.9% | 917,000 | -20.9% | 2.14% | +6.0% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $39,607,000 | -38.2% | 840,911 | -35.3% | 1.42% | -37.0% |
| GKOS | Sell | GLAUKOS CORP | $36,951,000 | +20.6% | 569,356 | -24.5% | 1.32% | +23.0% |
| CNC | Sell | CENTENE CORP DEL | $35,471,000 | -11.3% | 245,000 | -24.5% | 1.27% | -9.5% |
| SEM | Sell | SELECT MED HLDGS CORP | $28,078,000 | -16.7% | 1,526,000 | -17.9% | 1.01% | -15.0% |
| KNSA | Sell | KINIKSA PHARMACEUTICALS LTD | $27,080,000 | +27.2% | 1,061,956 | -13.4% | 0.97% | +29.7% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $26,853,000 | -8.9% | 348,200 | -0.5% | 0.96% | -7.1% |
| ANTM | Sell | ANTHEM INC | $26,035,000 | -42.7% | 95,000 | -50.3% | 0.93% | -41.6% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $24,037,000 | +12.8% | 294,000 | -51.8% | 0.86% | +15.0% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $22,675,000 | -29.3% | 320,000 | -33.7% | 0.81% | -28.0% |
| BOLD | Sell | AUDENTES THERAPEUTICS INC | $19,554,000 | -51.2% | 493,901 | -52.9% | 0.70% | -50.2% |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $17,648,000 | +4.4% | 1,087,359 | -17.1% | 0.63% | +6.6% |
| AIMT | Sell | AIMMUNE THERAPEUTICS INC | $15,086,000 | -16.6% | 553,000 | -17.8% | 0.54% | -15.1% |
| SIEN | Sell | SIENTRA INC | $14,179,000 | +12.0% | 593,769 | -8.5% | 0.51% | +14.2% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $12,129,000 | -78.6% | 283,115 | -89.0% | 0.43% | -78.2% |
| NVTA | Sell | INVITAE CORP | $11,511,000 | -17.6% | 688,062 | -63.8% | 0.41% | -16.1% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $10,667,000 | -51.5% | 365,689 | -48.0% | 0.38% | -50.5% |
| MLNT | Sell | MELINTA THERAPEUTICS INC | $9,132,000 | -64.0% | 2,311,858 | -42.1% | 0.33% | -63.3% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $8,974,000 | -42.9% | 239,000 | -39.9% | 0.32% | -41.8% |
| BLUE | Sell | BLUEBIRD BIO INC | $8,970,000 | -49.4% | 61,435 | -45.6% | 0.32% | -48.5% |
| PFNX | Sell | PFENEX INC | $5,465,000 | -10.6% | 1,069,514 | -5.3% | 0.20% | -8.8% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $5,052,000 | -84.5% | 29,249 | -87.4% | 0.18% | -84.2% |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $3,879,000 | -43.9% | 612,867 | -32.9% | 0.14% | -42.8% |
| BIOS | Sell | BIOSCRIP INC | $3,172,000 | -53.6% | 1,023,379 | -56.2% | 0.11% | -52.5% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $2,134,000 | -0.8% | 58,247 | -27.9% | 0.08% | 0.0% |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $1,345,000 | -60.2% | 234,745 | -65.2% | 0.05% | -59.7% |
| ARLZ | Exit | ARALEZ PHARMACEUTICALS INC | $0 | – | -1,644,583 | -100.0% | -0.02% | – |
| NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -233,332 | -100.0% | -0.05% | – |
| XNCR | Exit | XENCOR INC | $0 | – | -48,366 | -100.0% | -0.06% | – |
| MNKD | Exit | MANNKIND CORP | $0 | – | -1,458,537 | -100.0% | -0.10% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -125,000 | -100.0% | -0.12% | – |
| STDY | Exit | STEADYMED LTD | $0 | – | -918,120 | -100.0% | -0.14% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -1,764,889 | -100.0% | -0.18% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -200,000 | -100.0% | -0.20% | – |
| SLDB | Exit | SOLID BIOSCIENCES INC | $0 | – | -179,381 | -100.0% | -0.22% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -178,806 | -100.0% | -0.24% | – |
| ECOR | Exit | ELECTROCORE INC | $0 | – | -425,000 | -100.0% | -0.25% | – |
| TBIO | Exit | TRANSLATE BIO INC | $0 | – | -650,000 | -100.0% | -0.29% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -349,539 | -100.0% | -0.32% | – |
| IVTY | Exit | INVUITY INC | $0 | – | -2,336,889 | -100.0% | -0.32% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -628,262 | -100.0% | -0.32% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -600,000 | -100.0% | -0.34% | – |
| Exit | AEGERION PHARMACEUTICALS INCnote 2.000% 8/1 | $0 | – | -16,600,000 | -100.0% | -0.38% | – | |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -146,000 | -100.0% | -0.50% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -165,175 | -100.0% | -0.55% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -168,000 | -100.0% | -0.58% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -398,194 | -100.0% | -0.61% | – |
| Exit | RADIUS HEALTH INCnote 3.000% 9/0 | $0 | – | -21,000,000 | -100.0% | -0.68% | – | |
| NTRA | Exit | NATERA INC | $0 | – | -1,080,829 | -100.0% | -0.71% | – |
| Exit | DEPOMED INCnote 2.500% 9/0 | $0 | – | -27,019,000 | -100.0% | -0.77% | – | |
| LCI | Exit | LANNET INC | $0 | – | -1,801,353 | -100.0% | -0.86% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -531,000 | -100.0% | -1.12% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -550,000 | -100.0% | -1.24% | – |
| Exit | TRINITY BIOTECH INVT LTDnote 4.000% 4/0 | $0 | – | -43,000,000 | -100.0% | -1.24% | – | |
| Exit | ENDOLOGIX INCnote 3.250%11/0 | $0 | – | -40,500,000 | -100.0% | -1.34% | – | |
| AET | Exit | AETNA INC NEW | $0 | – | -229,000 | -100.0% | -1.48% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -6,988,248 | -100.0% | -4.58% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.